Picture of Chiome Bioscience logo

4583 Chiome Bioscience Income Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Chiome Bioscience, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue448481713631682
Cost of Revenue
Gross Profit285245422349399
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,8411,7632,1841,8831,885
Operating Profit-1,393-1,283-1,471-1,253-1,203
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1,401-1,291-1,466-1,238-1,215
Provision for Income Taxes
Net Income After Taxes-1,404-1,294-1,480-1,243-1,220
Net Income Before Extraordinary Items
Net Income-1,404-1,294-1,480-1,243-1,220
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1,404-1,294-1,480-1,243-1,220
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-44.8-36.1-34.5-28.3-24.7
Dividends per Share